Medicaid Coverage Scrutiny Raises New Questions on Ivermectin Access
In 2025, Medicaid has become a central point of debate in the U.S. healthcare landscape. With the Centers for Medicare & Medicaid Services (CMS) conducting stricter coverage audits, questions about Ivermectin Medicaid coverage review USA have reemerged—especially for vulnerable populations who rely on public insurance. What once seemed like a niche policy issue has now...